_version_ 1783469108881260544
author Girotti, Maria Romina
Lopes, Filipa
Preece, Natasha
Niculescu-Duvaz, Dan
Zambon, Alfonso
Davies, Lawrence
Whittaker, Steven
Saturno, Grazia
Viros, Amaya
Pedersen, Malin
Suijkerbuijk, Bart M.J.M.
Menard, Delphine
McLeary, Robert
Johnson, Louise
Fish, Laura
Ejiama, Sarah
Sanchez-Laorden, Berta
Hohloch, Juliane
Carragher, Neil
Macleod, Kenneth
Ashton, Garry
Marusiak, Anna A.
Fusi, Alberto
Brognard, John
Frame, Margaret
Lorigan, Paul
Marais, Richard
Springer, Caroline
author_facet Girotti, Maria Romina
Lopes, Filipa
Preece, Natasha
Niculescu-Duvaz, Dan
Zambon, Alfonso
Davies, Lawrence
Whittaker, Steven
Saturno, Grazia
Viros, Amaya
Pedersen, Malin
Suijkerbuijk, Bart M.J.M.
Menard, Delphine
McLeary, Robert
Johnson, Louise
Fish, Laura
Ejiama, Sarah
Sanchez-Laorden, Berta
Hohloch, Juliane
Carragher, Neil
Macleod, Kenneth
Ashton, Garry
Marusiak, Anna A.
Fusi, Alberto
Brognard, John
Frame, Margaret
Lorigan, Paul
Marais, Richard
Springer, Caroline
author_sort Girotti, Maria Romina
collection PubMed
description
format Online
Article
Text
id pubmed-6848950
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-68489502019-11-15 Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma Girotti, Maria Romina Lopes, Filipa Preece, Natasha Niculescu-Duvaz, Dan Zambon, Alfonso Davies, Lawrence Whittaker, Steven Saturno, Grazia Viros, Amaya Pedersen, Malin Suijkerbuijk, Bart M.J.M. Menard, Delphine McLeary, Robert Johnson, Louise Fish, Laura Ejiama, Sarah Sanchez-Laorden, Berta Hohloch, Juliane Carragher, Neil Macleod, Kenneth Ashton, Garry Marusiak, Anna A. Fusi, Alberto Brognard, John Frame, Margaret Lorigan, Paul Marais, Richard Springer, Caroline Cancer Cell Article Cell Press 2017-03-13 /pmc/articles/PMC6848950/ /pubmed/28292443 http://dx.doi.org/10.1016/j.ccell.2017.02.007 Text en © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Article
Girotti, Maria Romina
Lopes, Filipa
Preece, Natasha
Niculescu-Duvaz, Dan
Zambon, Alfonso
Davies, Lawrence
Whittaker, Steven
Saturno, Grazia
Viros, Amaya
Pedersen, Malin
Suijkerbuijk, Bart M.J.M.
Menard, Delphine
McLeary, Robert
Johnson, Louise
Fish, Laura
Ejiama, Sarah
Sanchez-Laorden, Berta
Hohloch, Juliane
Carragher, Neil
Macleod, Kenneth
Ashton, Garry
Marusiak, Anna A.
Fusi, Alberto
Brognard, John
Frame, Margaret
Lorigan, Paul
Marais, Richard
Springer, Caroline
Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
title Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
title_full Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
title_fullStr Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
title_full_unstemmed Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
title_short Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
title_sort paradox-breaking raf inhibitors that also target src are effective in drug-resistant braf mutant melanoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848950/
https://www.ncbi.nlm.nih.gov/pubmed/28292443
http://dx.doi.org/10.1016/j.ccell.2017.02.007
work_keys_str_mv AT girottimariaromina paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT lopesfilipa paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT preecenatasha paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT niculescuduvazdan paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT zambonalfonso paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT davieslawrence paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT whittakersteven paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT saturnograzia paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT virosamaya paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT pedersenmalin paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT suijkerbuijkbartmjm paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT menarddelphine paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT mclearyrobert paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT johnsonlouise paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT fishlaura paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT ejiamasarah paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT sanchezlaordenberta paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT hohlochjuliane paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT carragherneil paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT macleodkenneth paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT ashtongarry paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT marusiakannaa paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT fusialberto paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT brognardjohn paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT framemargaret paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT loriganpaul paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT maraisrichard paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma
AT springercaroline paradoxbreakingrafinhibitorsthatalsotargetsrcareeffectiveindrugresistantbrafmutantmelanoma